Location History:
- Heidelberg, DE (2021)
- Edingen-Neckarhausen, DE (2021 - 2023)
Company Filing History:
Years Active: 2021-2025
Title: The Innovative Contributions of Thorsten Ross
Introduction
Thorsten Ross is a notable inventor based in Edingen-Neckarhausen, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. With a total of five patents to his name, Ross continues to push the boundaries of innovation in his field.
Latest Patents
Among his latest patents is the "Tandem diabody for CD16A-directed NK-cell engagement." This invention relates to a multispecific antigen-binding molecule that specifically binds to CD16A. It consists of two polypeptide chains, each comprising at least four variable domains arranged in a specific order. Another significant patent is for "Multivalent FV antibodies," which pertains to a trispecific antibody molecule. This molecule may include a diabody-unit integrated into a polypeptide chain with at least six variable domains linked sequentially. In certain instances, two single-chain Fv (scFv) fragments are distally connected to the diabody-unit, providing additional antigen binding sites.
Career Highlights
Thorsten Ross is currently associated with Affimed GmbH, a company known for its innovative approaches in immunotherapy. His work at Affimed has allowed him to explore and develop groundbreaking technologies that enhance the efficacy of therapeutic antibodies.
Collaborations
Ross collaborates with esteemed colleagues such as Uwe Reusch and Erich Rajkovic. Their combined expertise contributes to the advancement of research and development in the field of antibody engineering.
Conclusion
Thorsten Ross exemplifies the spirit of innovation in biotechnology through his patents and collaborative efforts. His work continues to influence the development of novel therapeutic solutions.